Blogs
-
AAV Serotype Screening: A Key Step for Optimizing Gene Delivery and Accelerating Research
Jun 15 2026 -
How molecular, protein-level, and functional assays confirm successful AAV-based gene disruption
Jun 12 2026 -
How AAV-mediated SaCas9 delivery supports targeted gene disruption in living tissues
Jun 10 2026 -
How recombinant AAV vectors are designed, assembled, purified, and characterized for reliable gene transfer
Jun 08 2026 -
How PackGene supports customized AAV vector design, production, purification, and quality control
Jun 05 2026 -
AAV Titer Testing: A Critical Step in Gene Therapy Vector Characterization
Jun 03 2026 -
AAV Empty/Full Capsid Ratio Analysis: Key Methods for Improving Vector Quality in Gene Therapy Manufacturing
Jun 01 2026 -
Muscle-Tropic AAV Capsid Variants: Advancing Targeted Gene Delivery for Neuromuscular Disease Research
May 29 2026 -
AAV Applications in Peripheral Tissues: Expanding the Reach of Gene Therapy Beyond the CNS
May 27 2026